STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Catalyst Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Catalyst Pharmaceuticals (Nasdaq: CPRX) announced that President & CEO Rich Daly and other management will participate in Citi’s 2025 Global Healthcare Conference in Miami on Tuesday, December 2, 2025.

The company’s presentation is scheduled for 1:00 PM ET. A live webcast will be available via the Investors section at www.catalystpharma.com, and a replay will be available for at least 30 days after the presentation.

Catalyst Pharmaceuticals (Nasdaq: CPRX) ha annunciato che il presidente e CEO Rich Daly e altri membri della direzione parteciperanno alla Citi’s 2025 Global Healthcare Conference a Miami martedì, 2 dicembre 2025.

La presentazione dell’azienda è prevista per 1:00 PM ET. Una trasmissione in diretta sarà disponibile tramite la sezione Investitori su www.catalystpharma.com, e una replica sarà disponibile per almeno 30 giorni dopo la presentazione.

Catalyst Pharmaceuticals (Nasdaq: CPRX) anunció que el presidente y CEO Rich Daly y otros directivos participarán en Citi’s 2025 Global Healthcare Conference en Miami el martes 2 de diciembre de 2025.

La presentación de la empresa está programada para las 1:00 PM ET. Habrá una transmisión en vivo disponible a través de la sección de Inversores en www.catalystpharma.com, y una repetición estará disponible por al menos 30 días después de la presentación.

Catalyst Pharmaceuticals (Nasdaq: CPRX)는 Rich Daly 사장 겸 CEO와 다른 경영진이 Citi’s 2025 Global Healthcare Conference에 마이애미에서 참석할 것이라고 발표했습니다. 날짜는 2025년 12월 2일 화요일입니다.

회사 발표는 1:00 PM ET로 예정되어 있습니다. 라이브 웹캐스트는 www.catalystpharma.com의 투자자 섹션에서 이용 가능하며, 발표 후 적어도 30일간 재생 가능합니다.

Catalyst Pharmaceuticals (Nasdaq: CPRX) a annoncé que le président-directeur général Rich Daly et d’autres dirigeants participeront à la Citi’s 2025 Global Healthcare Conference à Miami le mardi 2 décembre 2025.

La présentation de l’entreprise est prévue pour 13 h 00 ET. Une webdiffusion en direct sera disponible via la section Investisseurs sur www.catalystpharma.com, et une rediffusion sera disponible pendant au moins 30 jours après la présentation.

Catalyst Pharmaceuticals (Nasdaq: CPRX) gab bekannt, dass Präsident und CEO Rich Daly sowie weitere Führungskräfte an der Citi’s 2025 Global Healthcare Conference in Miami am Dienstag, dem 2. Dezember 2025 teilnehmen werden.

Die Präsentation des Unternehmens ist für 13:00 Uhr ET vorgesehen. Ein Live-Webcast wird im Bereich Investor-Relations unter www.catalystpharma.com verfügbar sein, und eine Wiederholung wird mindestens 30 Tage nach der Präsentation abrufbar sein.

Catalyst Pharmaceuticals (Nasdaq: CPRX) أعلنت أن الرئيس التنفيذي Rich Daly وأعضاء الإدارة الآخرين سيشاركون في Citi’s 2025 Global Healthcare Conference في ميامي يوم الثلاثاء، 2 ديسمبر 2025.

من المقرر أن تكون عرض الشركة في 1:00 PM ET. سيكون هناك بث مباشر متاح عبر قسم المستثمرين على www.catalystpharma.com، وسيكون بإمكانك مشاهدة إعادة العرض مدة لا تقل عن 30 يوماً بعد العرض.

Positive
  • None.
Negative
  • None.

CORAL GABLES, Fla., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that Rich Daly, President and CEO, along with other members of Catalyst's management team, will participate in Citi’s 2025 Global Healthcare Conference in Miami on Tuesday, December 2, 2025.

Date of Presentation: Tuesday, December 2, 2025
Time: 1:00pm ET
Webcast Link

The webcast will be available under the Investors section on the Company's website, www.catalystpharma.com, and a replay will be available for at least 30 days.

About Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX), is a biopharmaceutical company committed to improving the lives of patients with rare diseases. With a proven track record of bringing life-changing treatments to the market, we focus on in-licensing, commercializing, and developing innovative therapies. Guided by our deep commitment to patient care, we prioritize accessibility, ensuring patients receive the care they need through a comprehensive suite of support services designed to provide seamless access and ongoing assistance. Catalyst maintains a well-established U.S. presence, which remains the cornerstone of our commercial strategy, while continuously evaluating strategic opportunities to expand our global footprint. Catalyst, headquartered in Coral Gables, Fla., was recognized on the Forbes 2025 list as one of America's Most Successful Mid-Cap Companies and on the 2024 Deloitte Technology Fast 500™ list as one of North America’s Fastest-Growing Companies.

For more information, please visit Catalyst's website at www.catalystpharma.com.

Forward-Looking Statements

This press release contains forward-looking statements, as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause Catalyst's actual results in future periods to differ materially from forecasted results. A number of factors, including those factors described in Catalyst's Annual Report on Form 10-K for the fiscal year 2024 and its subsequent filings with the U.S. Securities and Exchange Commission ("SEC"), could adversely affect Catalyst. Copies of Catalyst's filings with the SEC are available from the SEC, may be found on Catalyst's website, or may be obtained upon request from Catalyst. Catalyst does not undertake any obligation to update the information contained herein, which speaks only as of this date.



Investor Contact
Melissa Kendis, Catalyst Pharmaceuticals, Inc.
(305) 420-3200
IR@catalystpharma.com

Media Contact
David Schull or Olipriya Das, Russo Partners
(858) 717-2310, 646 942 5588
david.schull@russopartnersllc.com, Olipriya.das@russopartnersllc.com

FAQ

When will Catalyst Pharmaceuticals (CPRX) present at Citi’s 2025 Global Healthcare Conference?

Catalyst will present on Tuesday, December 2, 2025 at 1:00 PM ET.

How can investors watch Catalyst Pharmaceuticals (CPRX) at Citi’s 2025 Global Healthcare Conference?

Investors can watch the live webcast via the Investors section at www.catalystpharma.com.

Will there be a replay of Catalyst Pharmaceuticals (CPRX) presentation from Citi’s 2025 Global Healthcare Conference?

Yes. A replay will be available on the company website for at least 30 days after the presentation.

Who from Catalyst Pharmaceuticals (CPRX) will speak at Citi’s 2025 Global Healthcare Conference?

Rich Daly, President and CEO, will present alongside other members of Catalyst’s management team.

What time is the Catalyst Pharmaceuticals (CPRX) webcast on December 2, 2025?

The webcast is scheduled to begin at 1:00 PM ET on December 2, 2025.
Catalyst Pharmaceuticals Inc

NASDAQ:CPRX

CPRX Rankings

CPRX Latest News

CPRX Latest SEC Filings

CPRX Stock Data

2.77B
115.38M
6.4%
85.49%
6.48%
Biotechnology
Pharmaceutical Preparations
Link
United States
CORAL GABLES